A report from pediatricians and toxicologists raises doubts about the insulin testing that played a crucial role in Lucy Letby's conviction, as her legal team pursues an appeal against her life sentences.
Experts Question Validity of Insulin Test in Lucy Letby's Case
Experts Question Validity of Insulin Test in Lucy Letby's Case
New findings challenge the reliability of evidence used in the conviction of the nurse accused of murdering infants.
Seven pediatric doctors and toxicology experts have come forward to assert that the prosecution's reliance on insulin tests during the trial of nurse Lucy Letby was fundamentally flawed. These claims were made in a report submitted to the Criminal Cases Review Commission in Britain, which is tasked with examining potential miscarriages of justice. Letby was convicted in 2023 of the murder of seven babies under her care at a neonatal unit in a northern English hospital.
Her lawyer, Mark McDonald, introduced this new expert analysis, hoping to support Letby’s ongoing assertion of innocence and to advocate for a full appeal against her 15-life sentence conviction. The report, which features assessments from a variety of medical experts, criticizes the integrity of the insulin-related evidence used to charge Letby. It states, “Our inescapable conclusion is that this evidence significantly undermines the validity of the assertions made about the insulin and C-peptide testing presented in Court.”
Letby's case has drawn significant public and media scrutiny, especially following a detailed article in The New Yorker last year that questioned her guilt. Despite the emerging concerns and calls for a reassessment of her case, Letby’s legal team has faced repeated denials in their attempts for a new trial.
